![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
在患有重度耐火性CANOMAD的患者中,对用达拉图穆马布治疗抗CD38药物有很好的反应
Elba Pascual-Goñi1, Roger Collet2, Clara Tejada-Illa2
1Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain epascualg@santpau.cat.
Journal of neurology, neurosurgery, and psychiatry
|February 10, 2024
概括
达拉图马布提供了一种有前途的新疗法,用于治疗严重的慢性性心力衰竭神经病变和眼睛,使用IgM-偏蛋白,冷凝固素和抗迪沙洛西尔抗体 (CANOMAD). 这种疗法成功治疗了对标准治疗不耐药的患者,导致完全康复.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性性神经病变和眼膜与IgM-paraprotein,冷Agglutinins和抗Disialosyl抗体 (CANOMAD) 通常用IVIG和rituximab治疗,达到50%的应答率.
- 达拉图马布是一种抗CD38疗法,向长寿的血细胞,并显示出耐火抗体介导疾病的潜力.
研究的目的:
- 报告第一个成功治疗严重的,耐火的CANOMAD使用daratumumab.
- 评估达拉图穆马布在患有侵袭性,耐治疗性CANOMAD的患者的疗效和安全性.
主要方法:
- 一名患有重症,复发性CANOMAD耐药性的患者接受了多种治疗,包括IVIG,rituximab和ibrutinib,并接受了daratumumab治疗.
- 达拉图穆马布被静脉注射,剂量和频率随着时间的推移而调整.
- 血交换 (PE) 用于初始稳定.
主要成果:
- 患者在开始服用达拉图马布后3周内完全康复,停止了PE的依赖.
- 抗disialosyl抗体标位下降,血清神经纤维光链水平在治疗后正常化.
- 患者在月度达拉图姆巴维护疗法下保持了临床缓解12个月.
结论:
- 达拉图姆巴显示出作为治疗严重,耐火性CANOMAD和其他IgM相关神经病变的有效治疗的潜力.
- 这个案例为达拉图穆马布在激进抗体介导的神经疾病中的有效性提供了原则证明.
关键词:
神经病变是一种神经病变.更多相关视频
08:04In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
11.7K
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.3K
相关概念视频
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K